isoxazoles and Heart Failure
isoxazoles has been researched along with Heart Failure in 11 studies
Research
Studies (11)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (9.09) | 18.2507 |
2000's | 9 (81.82) | 29.6817 |
2010's | 1 (9.09) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Baicu, CF; Bourge, RC; Little, WC; Redfield, MM; Zhou, D; Zile, MR | 1 |
Bauer, M; Dietl, W; Hallström, S; Jürgens, G; Podesser, BK; Trescher, K; Ullrich, R; Wick, N; Wolfsberger, M; Wolner, E | 1 |
Colucci, WS; Givertz, MM; Ooi, H | 1 |
Lüscher, TF; Spieker, LE | 1 |
Clark, AL; Cleland, JG; Coletta, AP; Lammiman, M; Loh, H; Nasir, M; Witte, KK | 1 |
Deray, G; Héloire, F; Valat, JP | 1 |
Abbate, A; Baldi, A; Biasucci, LM; Biondi-Zoccai, GG; Crea, F; Fowler, AA; Kukreja, RC; Lipinski, MJ; Ockaili, RA; Salloum, FN; Straino, S; Vetrovec, GW | 1 |
Batyraliev, TA; Ekinsi, E; Makhmutkhodzhaev, SA; Pataraia, SA; Pershukov, IV; Preobrazhenskiĭ, DV; Sidorenko, BA | 1 |
Park, MH | 1 |
Wu-Wong, JR | 1 |
Reviews
6 review(s) available for isoxazoles and Heart Failure
Article | Year |
---|---|
Will endothelin receptor antagonists have a role in heart failure?
Topics: Animals; Bosentan; Cardiovascular Agents; Clinical Trials as Topic; Endothelin Receptor Antagonists; Endothelins; Heart Failure; Humans; Isoxazoles; Oligopeptides; Peptides, Cyclic; Phenylpropionates; Piperidines; Pyridines; Pyrimidines; Sulfonamides; Tetrazoles; Thiophenes; Treatment Outcome | 2003 |
Clinical trials update from the European Society of Cardiology meeting 2005: CARE-HF extension study, ESSENTIAL, CIBIS-III, S-ICD, ISSUE-2, STRIDE-2, SOFA, IMAGINE, PREAMI, SIRIUS-II and ACTIVE.
Topics: Cardiac Pacing, Artificial; Cardiology; Congresses as Topic; Defibrillators, Implantable; Enalapril; Enoximone; Europe; Female; Follow-Up Studies; Heart Failure; Humans; Isoxazoles; Male; Randomized Controlled Trials as Topic; Risk Assessment; Severity of Illness Index; Societies, Medical; Survival Analysis; Thiophenes; Treatment Outcome | 2005 |
[Are there any differences in the cardiovascular tolerance between classical NSAIDs and coxibs?].
Topics: Age Factors; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Case-Control Studies; Celecoxib; Cohort Studies; Cyclooxygenase 2 Inhibitors; Diclofenac; Edema; Heart Failure; Humans; Hypertension; Isoxazoles; Lactones; Meta-Analysis as Topic; Middle Aged; Odds Ratio; Placebos; Prospective Studies; Pyrazoles; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Assessment; Risk Factors; Sulfonamides; Sulfones; Thrombosis; Time Factors | 2006 |
[Pulmonary hypertension and right ventricular failure. Part XI. Endothelin receptor blockers in the treatment of primary pulmonary arterial hypertension].
Topics: Antihypertensive Agents; Bosentan; Endothelin Receptor Antagonists; Heart Failure; Hemodynamics; Humans; Hypertension, Pulmonary; Isoxazoles; Phenylpropionates; Pyridazines; Sulfonamides; Thiophenes; Ventricular Dysfunction, Right | 2007 |
Advances in diagnosis and treatment in patients with pulmonary arterial hypertension.
Topics: Antihypertensive Agents; Bosentan; Cardiac Catheterization; Disease Progression; Drug Therapy, Combination; Endothelin Receptor Antagonists; Endothelium, Vascular; Epoprostenol; Heart Failure; Humans; Hypertension, Pulmonary; Iloprost; Isoxazoles; Phosphodiesterase Inhibitors; Piperazines; Platelet Aggregation Inhibitors; Prognosis; Pulmonary Artery; Purines; Sildenafil Citrate; Sulfonamides; Sulfones; Thiophenes; Vasoconstriction | 2008 |
Sitaxsentan (ICOS-Texas Biotechnology).
Topics: Animals; Clinical Trials as Topic; Endothelin Receptor Antagonists; Heart Failure; Humans; Isoxazoles; Lung Diseases, Obstructive; Receptor, Endothelin A; Subarachnoid Hemorrhage; Thiophenes | 2001 |
Trials
2 trial(s) available for isoxazoles and Heart Failure
Article | Year |
---|---|
Randomized, double-blind, placebo-controlled study of sitaxsentan to improve impaired exercise tolerance in patients with heart failure and a preserved ejection fraction.
Topics: Aged; Analysis of Variance; Double-Blind Method; Echocardiography; Endothelin Receptor Antagonists; Exercise Tolerance; Female; Heart Failure; Humans; Isoxazoles; Male; Stroke Volume; Thiophenes; Treatment Outcome; Ventricular Function, Left | 2014 |
Endothelin mediates increased pulmonary vascular tone in patients with heart failure: demonstration by direct intrapulmonary infusion of sitaxsentan.
Topics: Blood Flow Velocity; Blood Pressure; Endothelin Receptor Antagonists; Endothelins; Female; Heart Failure; Humans; Hypertension, Pulmonary; Infusions, Intra-Arterial; Isoxazoles; Male; Middle Aged; Pulmonary Artery; Pulmonary Circulation; Receptor, Endothelin A; Reference Values; Thiophenes; Vascular Resistance; Vasomotor System; Ventricular Function, Left | 2002 |
Other Studies
3 other study(ies) available for isoxazoles and Heart Failure
Article | Year |
---|---|
Improved myocardial protection in the failing heart by selective endothelin-A receptor blockade.
Topics: Animals; Cardiovascular Agents; Disease Models, Animal; Endothelin A Receptor Antagonists; Heart; Heart Failure; Isoxazoles; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Rats; Rats, Sprague-Dawley; Sulfonamides | 2009 |
Improvement of cardiac function with parecoxib, a cyclo-oxygenase-2 inhibitor, in a rat model of ischemic heart failure.
Topics: Animals; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Echocardiography; Heart Failure; Heart Function Tests; Isoxazoles; Male; Myocardial Ischemia; Myocardium; Rats; Rats, Wistar | 2007 |
TBC 11251. IPI 1040.
Topics: Animals; Clinical Trials, Phase I as Topic; Drugs, Investigational; Endothelin Receptor Antagonists; Heart Failure; Humans; Isoxazoles; Receptor, Endothelin A; Thiophenes | 1999 |